跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gentalyf - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gentalyf
Approved
STANDARD
Gentalyf
Egyptian International Pharmaceutical Industries Co. (EIPICO)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7c2614cc69f35715
Company
Egyptian International Pharmaceutical Industries Co. (EIPICO)
Type
Standard
Approval Details
Approval Id
7c2614cc69f35715
Drug Approval Philippines Name
Gentalyf
Product Name
Gentalyf
Registration Number
DRP-10946-03
Brand Name
Gentalyf
Generic Name
Gentamicin (as sulfate)
Dosage Form
Ophthalmic/Otic Solution (Drops)
Dosage Strength
3mg/mL (0.3% w/v)
Manufacturer
Egyptian International Pharmaceutical Industries Co. (EIPICO)
Importer
Ambica International Corporation
Distributor
AGB Pharmaceutical Trading and Consultancy Corporation
Issuance Date
24 March 2024
Expiry Date
21 December 2026
Pharmacologic Category
Antibacterial (Aminoglycoside)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7c2614cc69f35715
Type
Standard
Back to Philippines FDA Approvals